These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11226818)

  • 1. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride.
    Tegtmeyer S; Papantoniou I; Müller-Goymann CC
    Eur J Pharm Biopharm; 2001 Mar; 51(2):119-25. PubMed ID: 11226818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human corneal equivalent as cell culture model for in vitro drug permeation studies.
    Reichl S; Bednarz J; Müller-Goymann CC
    Br J Ophthalmol; 2004 Apr; 88(4):560-5. PubMed ID: 15031177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of an organotypic corneal construction as an in vitro model for permeability studies].
    Reichl S; Müller-Goymann CC
    Ophthalmologe; 2001 Sep; 98(9):853-8. PubMed ID: 11594225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultivation and characterization of a bovine in vitro model of the cornea.
    Tegtmeyer S; Reichl S; Müller-Goymann CC
    Pharmazie; 2004 Jun; 59(6):464-71. PubMed ID: 15248462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride.
    Reichl S; Müller-Goymann CC
    Int J Pharm; 2003 Jan; 250(1):191-201. PubMed ID: 12480285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].
    Meyer L; Bednarz J; Müller-Goymann CC; Reichl S
    Ophthalmologe; 2005 Oct; 102(10):971-80. PubMed ID: 15785910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas.
    Reichl S; Döhring S; Bednarz J; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Jul; 60(2):305-8. PubMed ID: 15939241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
    Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
    Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of alpha-cyclodextrin and hydroxyalkylated beta-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions.
    Siefert B; Keipert S
    J Pharm Sci; 1997 Jun; 86(6):716-20. PubMed ID: 9188054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of pH on the permeation of pilocarpine and pilocarpine prodrugs across the isolated rabbit cornea.
    Suhonen P; Järvinen T; Koivisto S; Urtti A
    Eur J Pharm Sci; 1998 Jul; 6(3):169-76. PubMed ID: 9795043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
    Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
    Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].
    Wei J; He HL; Zheng CL; Zhu JB
    Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micellar solutions of triblock copolymer surfactants with pilocarpine.
    Pepić I; Jalsenjak N; Jalsenjak I
    Int J Pharm; 2004 Mar; 272(1-2):57-64. PubMed ID: 15019069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of transcorneal permeation of pilocarpine.
    Mitra AK; Mikkelson TJ
    J Pharm Sci; 1988 Sep; 77(9):771-5. PubMed ID: 3225772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.
    Rathore MS; Majumdar DK
    AAPS PharmSciTech; 2006 Jul; 7(3):57. PubMed ID: 17025238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical corneal permeation model for ionizable drugs.
    Friedrich SW; Cheng YL; Saville BA
    J Ocul Pharmacol; 1993; 9(3):229-49. PubMed ID: 8228531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
    Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
    Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.